Catherine Schulte
Stock Analyst at Baird
(4.08)
# 472
Out of 4,843 analysts
128
Total ratings
55.56%
Success rate
10.07%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Outperform | $159 → $140 | $111.92 | +25.09% | 16 | May 22, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $3 → $2 | $2.25 | -11.11% | 6 | May 13, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $69 → $72 | $56.28 | +27.93% | 14 | May 2, 2025 | |
| AVTR Avantor | Maintains: Outperform | $21 → $17 | $12.91 | +31.68% | 11 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $603 → $573 | $402.82 | +42.25% | 26 | Apr 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $231 → $225 | $189.90 | +18.48% | 8 | Apr 23, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,369 → $1,034 | $1,155.52 | -10.52% | 8 | Apr 22, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $42 → $43 | $45.13 | -4.72% | 4 | Apr 21, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $48.40 | +40.50% | 10 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $15.97 | +137.95% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $29.30 | +12.63% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $82.24 | +241.68% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $349.24 | -37.87% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $157.73 | -87.32% | 1 | Jun 28, 2018 |
Agilent Technologies
May 22, 2025
Maintains: Outperform
Price Target: $159 → $140
Current: $111.92
Upside: +25.09%
Maravai LifeSciences Holdings
May 13, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $2.25
Upside: -11.11%
Exact Sciences
May 2, 2025
Maintains: Outperform
Price Target: $69 → $72
Current: $56.28
Upside: +27.93%
Avantor
Apr 28, 2025
Maintains: Outperform
Price Target: $21 → $17
Current: $12.91
Upside: +31.68%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $603 → $573
Current: $402.82
Upside: +42.25%
Danaher
Apr 23, 2025
Maintains: Outperform
Price Target: $231 → $225
Current: $189.90
Upside: +18.48%
Mettler-Toledo International
Apr 22, 2025
Maintains: Neutral
Price Target: $1,369 → $1,034
Current: $1,155.52
Upside: -10.52%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $42 → $43
Current: $45.13
Upside: -4.72%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $48.40
Upside: +40.50%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $15.97
Upside: +137.95%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $29.30
Upside: +12.63%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $82.24
Upside: +241.68%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $349.24
Upside: -37.87%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $157.73
Upside: -87.32%